These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 36675125)

  • 1. A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation.
    Tyagi A; Pugazhenthi S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model.
    Tyagi A; Mirita C; Taher N; Shah I; Moeller E; Tyagi A; Chong T; Pugazhenthi S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165849. PubMed ID: 32485218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer's disease with metabolic syndrome.
    Tyagi A; Musa M; Labeikovsky W; Pugazhenthi S
    Sci Rep; 2022 Nov; 12(1):19808. PubMed ID: 36396721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System.
    Zhang H; Dai S; Yang Y; Wei J; Li X; Luo P; Jiang X
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain.
    Tyagi A; Nguyen CU; Chong T; Michel CR; Fritz KS; Reisdorph N; Knaub L; Reusch JEB; Pugazhenthi S
    Sci Rep; 2018 Dec; 8(1):17547. PubMed ID: 30510203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease.
    Lee J; Kim Y; Liu T; Hwang YJ; Hyeon SJ; Im H; Lee K; Alvarez VE; McKee AC; Um SJ; Hur M; Mook-Jung I; Kowall NW; Ryu H
    Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29130578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease.
    Pugazhenthi S
    Prog Mol Biol Transl Sci; 2017; 146():243-258. PubMed ID: 28253987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease.
    Ansari A; Rahman MS; Saha SK; Saikot FK; Deep A; Kim KH
    Aging Cell; 2017 Feb; 16(1):4-16. PubMed ID: 27686535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT3 and mitochondrial metabolism in neurodegenerative diseases.
    Salvatori I; Valle C; Ferri A; Carrì MT
    Neurochem Int; 2017 Oct; 109():184-192. PubMed ID: 28449871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial SIRT3 and neurodegenerative brain disorders.
    Anamika ; Khanna A; Acharjee P; Acharjee A; Trigun SK
    J Chem Neuroanat; 2019 Jan; 95():43-53. PubMed ID: 29129747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disorders.
    Mishra Y; Kaundal RK
    Drug Discov Today; 2023 Jun; 28(6):103583. PubMed ID: 37028501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Newly Synthesized Rhamnoside Derivative Alleviates Alzheimer's Amyloid-
    Li Y; Lu J; Cao X; Zhao H; Gao L; Xia P; Pei G
    Oxid Med Cell Longev; 2020; 2020():7698560. PubMed ID: 32104538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT3 weighs heavily in the metabolic balance: a new role for SIRT3 in metabolic syndrome.
    Green MF; Hirschey MD
    J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):105-7. PubMed ID: 22562958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
    Govindarajulu M; Ramesh S; Neel L; Fabbrini M; Buabeid M; Fujihashi A; Dwyer D; Lynd T; Shah K; Mohanakumar KP; Smith F; Moore T; Dhanasekaran M
    Neurochem Int; 2021 Mar; 144():104958. PubMed ID: 33444675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT3 Regulates Neuronal Excitability of Alzheimer's Disease Models in an Oxidative Stress-Dependent Manner.
    Ying Y; Lu C; Chen C; Liu Y; Liu YU; Ruan X; Yang Y
    Neuromolecular Med; 2022 Sep; 24(3):261-267. PubMed ID: 34687443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease.
    Shen Y; Wu Q; Shi J; Zhou S
    Biomed Pharmacother; 2020 Dec; 132():110928. PubMed ID: 33128944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
    You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
    Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT3 deficiency decreases oxidative metabolism capacity but increases lifespan in male mice under caloric restriction.
    Dhillon RS; Qin YA; van Ginkel PR; Fu VX; Vann JM; Lawton AJ; Green CL; Manchado-Gobatto FB; Gobatto CA; Lamming DW; Prolla TA; Denu JM
    Aging Cell; 2022 Dec; 21(12):e13721. PubMed ID: 36199173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial SIRT3 Deficiency Results in Neuronal Network Hyperexcitability, Accelerates Age-Related Aβ Pathology, and Renders Neurons Vulnerable to Aβ Toxicity.
    Perone I; Ghena N; Wang J; Mackey C; Wan R; Malla S; Gorospe M; Cheng A; Mattson MP
    Neuromolecular Med; 2023 Mar; 25(1):27-39. PubMed ID: 35749057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in characterization of SIRT3 deacetylation targets in mitochondrial function.
    Wang S; Zhang J; Deng X; Zhao Y; Xu K
    Biochimie; 2020 Dec; 179():1-13. PubMed ID: 32898647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.